National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, Tennessee, USA.
J Womens Health (Larchmt). 2023 Sep;32(9):899-904. doi: 10.1089/jwh.2023.0341. Epub 2023 Aug 8.
Substance use during pregnancy increases risk for a wide range of adverse maternal and neonatal health outcomes. Polysubstance use is common among people who use substances during pregnancy; however, the risks of combined substance exposures during pregnancy are poorly understood. In this report, we provide an overview of the activities of the Centers for Disease Control and Prevention (CDC) and partners and identified gaps related to (1) surveillance, (2) routine screening, and (3) prevention of polysubstance use during pregnancy. Efforts by CDC and other partners to reduce polysubstance use during pregnancy can improve the health of pregnant people and their infants and children.
怀孕期间使用物质会增加一系列不良母婴健康结果的风险。怀孕期间使用物质的人普遍存在多种物质使用情况；然而，对于怀孕期间联合物质暴露的风险知之甚少。在本报告中，我们提供了疾病预防控制中心 (CDC) 和合作伙伴的活动概述，并确定了与 (1) 监测、(2) 常规筛查和 (3) 预防怀孕期间多种物质使用相关的差距。CDC 和其他合作伙伴减少怀孕期间多种物质使用的努力可以改善孕妇及其婴儿和儿童的健康。
